Anticancer drug utilizing Trans-splicing Ribozyme technology Second Fast Track Designation following brain cancer approval SEONGNAM, South Korea, Feb. 18, 2025 /PRNewswire/ -- Rznomics announced on the 14th that its anticancer drug, RZ-001, has received Fast Track Designation from the U.S....
Read More Details
Finally We wish PressBee provided you with enough information of ( Rznomics Inc. Liver Cancer Drug Candidate Secures Fast Track Designation )
Also on site :
- Mel Owens' Ex-Wife Issues Bold Statement on His Upcoming 'Golden Bachelor' Season: 'It's Going to be Bad'
- European retailer inspired by ‘new Med’ hits major milestone opening its 50th store in the US – and 15 more are coming
- Al menos 9 personas muertas y 15 heridas por caída de un autobús a un río en México